Bacteraemia due to tribe proteeae: A review of 132 cases during a decade (1991-2000)

Scandinavian Journal of Infectious Diseases

Volumn 35, Issue 2, 2003, Pages 98-103

  Kim, Baek Nam ^a   Kim, Nam Joong ^b   Kim, Mi Na ^b   Kim, Yang Soo ^b   Woo, Jun Hee ^b   Ryu, Jiso ^b  

^a Dongsan Medical Center   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFAZOLIN; CEFOTAXIME; CEFUROXIME; CEPHAMYCIN; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; PIPERACILLIN; SULTAMICILLIN; TOBRAMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BILIARY TRACT DISEASE; BILIARY TRACT DRAINAGE; BILIARY TRACT INFECTION; CARDIOVASCULAR DISEASE; CATHETERIZATION; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HOSPITAL ADMISSION; HUMAN; INFANT; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MORALITY; MORGANELLA; MORGANELLA MORGANII; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENESIS; PROTEUS; PROTEUS MIRABILIS; PROTEUS PENNERI; PROTEUS VULGARIS; PROVIDENCIA; PROVIDENCIA STUARTII; SPECIES DIFFERENCE; URINARY TRACT DISEASE; URINARY TRACT INFECTION;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; INCIDENCE; KOREA; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MORGANELLA; PROBABILITY; PROGNOSIS; PROTEUS; PROTEUS INFECTIONS; PROVIDENCIA; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION;

EID: 0037244218     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/0036554021000027015     Document Type: Article

References (24)

1. Russo TA. Diseases caused by Gram-negative bacilli. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, eds. Harrison's principles of internal medicine. New York: McGraw-Hill, 2001: 953-60.
2. Watanakunakorn C, Perni SC. Proteus mirabilis bacteremia: a review of 176 cases during 1980-1992. Scand J Infect Dis 1994; 26: 361-7.
3. Adler JL, Burke JP, Martin DF, Finland M. Proteus infections in a general hospital. II. Some clinical and epidemiological characteristics. With an analysis of 71 cases of Proteus bacteremia. Ann Intern Med 1971; 75: 531-6.
4. Berger SA. Proteus bacteraemia in a general hospital 1972-1982. J Hosp Infect 1985; 6: 293-8.
5. Woods TD, Watanakunakorn C. Bacteremia due to Providencia stuartii: review of 49 episodes. South Med J 1996; 89: 221-4.
6. Rowen JL, Lopez SM. Morganella morganii early onset sepsis. Pediatr Infect Dis J 1998; 17: 1176-7.
7. McDermott C, Mylotte JM. Morganella morganii: epidemiology of bacteremic disease. Infect Control 1984; 5: 131-7.
8. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 9th Informational Suppl M100-S9. Wayne, PA: NCCLS; 1999.
9. McCabe WR, Jackson GG. Gram-negative bacteremia. II. Clinical, laboratory, and therapeutic observations. Arch Intern Med 1962; 110: 856-64.
10. Aleksic S, Bockemuhl J. Yersinia and other Enterobacteriaceae. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. Washington, DC: American Society of Microbiology, 1999: 483-96.
11. Lewis J, Fekety Jr FR. Proteus bacteremia. Johns Hopkins Med J 1969; 124: 151-69.
12. Prentice B, Robinson BL. A review of Providencia bacteremia in a general hospital, with a comment on patterns of antimicrobial sensitivity and use. Can Med Assoc J 1979; 121: 745-9.
13. Keren G, Tyrrel DL. Gram-negative septicemia caused by Providencia stuartii. Int J Pediatr Nephrol 1987; 8: 91-4.
14. Bagel J, Grossman ME. Hemorrhagic bullae associated with Morganella morganii septicemia. J Am Acad Dermatol 1985; 12: 575-6.
15. Samonis G, Anatoliotaki M, Apostolakou H, Souglakos J, Georgoulias V. Fatal septicemia and meningitis due to Morganella morganii in a patient with Hodgkin's disease. Scand J Infect Dis 2001; 33: 553-5.
16. Eisenstein BI, Zaleznik DF. Enterobacteriaceae. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. New York: Churchill Livingstone, 2000: 2294-310.
17. O'Hara CM, Brenner FW, Miller JM. Classification, identification, and clinical significance of Proteus, Providencia, and Morganella. Clin Microbiol Rev 2000; 13: 534-46.
18. Warren JW. Providencia stuartii: a common cause of antibiotic-resistant bacteriuria in patients with long-term indwelling catheters. Rev Infect Dis 1986; 8: 61-7.
19. Hawkey PM. Providencia stuartii: a review of a multiply antibiotic-resistant bacterium. J Antimicrob Chemother 1984; 13: 209-26.
20. Edwards LD, Cross A, Levin S, Landau W. Outbreak of a nosocomial infection with a strain of Proteus rettgeri resistant to many antimicrobials. Am J Clin Pathol 1974; 61: 41-6.
21. Washington JA, Senjem DH, Haldorson A, Schutt AH, Martin WJ. Nosocomially acquired bacteriuria due to Proteus rettgeri and Providencia stuartii. Am J Clin Pathol 1973; 60: 836-73.
22. Sahm DF, Storch G. AmpC beta-lactamases. Pediatr Infect Dis J 1998; 17: 421-2.
23. Livermore DM. Beta-lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995; 8: 557-84.
24. de Champs C, Bonnet R, Sirot D, Chanal C, Sirot J. Clinical relevance of Proteus mirabilis in hospital patients: a two year survey. J Antimicrob Chemother 2000; 45: 537-9.